Serious Infection Risk from the Filgotinib Drug Development Program Dr. Paul Studenic talks with Dr. James Galloway about abstract OP0126 presented at the virtual EULAR 2021 meeting. https://t.co/ymd8odsjAD https://t.co/d9fXGdmgOn